The Administrative Core (Admin Core) will serve as the executive, coordinating and oversight component of the Cincinnati Rheumatic Diseases Resource Center (CRDRC). The Admin Core will provide executive, administrative (including fiscal), and personnel services to the CRDRC, as well as scientific oversight of the resource cores. This includes coordination of resources within the Research Cores to enhance ongoing studies and promote new projects. The Admin Core will monitor progress and evaluate all aspects of the CRDRC's operations, including appropriate expenditures by the Resource Cores and Enrichment Program. The Admin Core will prepare required progress reports and regulatory documentation. Susan Thompson, Ph.D., is the proposed Director of the CRDRC, and Alexi Grom, M.D. is proposed as Associate Director. Dr. Grom will function as Medical Director of the CRDRC by providing the liaison to the rheumatology clinic and the fellowship training program. In addition, Dr. Peter Nigrovic, of Brigham and Women's Hospital and the current Chair of the CARRA (Childhood Arthritis Rheumatology Research Alliance) Translational Research and Technology Committee proposed as an Adjunct Associate Director of the CRDRC to liaison with the translational research community of CARRA. The CRDCC's chief executive and administrative body will be a five-member Executive Committee, which consists of the Director, Associate Director, and leaders of each Research Core. An Advisory Committee will provide advice to the Director and Executive Committee and will include local and external leaders with expertise to provide meaningful guidance to CRDRC leadership and Research Core directors. Members will include individuals experienced in core and center administration who are independent of the CRDRC, but who are part of, and familiar with, the academic setting within which the CRDRC resides or offer experiences of other comparable academic centers. Members will include individuals who complement the expertise of and utilize the Research Cores, and local leaders of programs that synergistically interact with the CRDRC. An Enrichment Program will be offered that includes research seminars, education relevant to technologies of the resource cores, and strategic planning of research goals. A novel and innovative P&F Program is proposed and will be managed by the Admin Core. Projects will be solicited locally and from the CARRA community. A P&F Study Committee will assist in the selection of new P&F Studies and monitor progress of ongoing P&F Studies. This program will provide a valuable mechanism for advancing new investigators and new projects in the field of pediatric rheumatology locally and nationally.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
1P30AR070549-01
Application #
9171178
Study Section
Special Emphasis Panel (ZAR1-YL (M1))
Project Start
2016-08-01
Project End
2021-07-31
Budget Start
2016-07-14
Budget End
2017-06-30
Support Year
1
Fiscal Year
2016
Total Cost
$180,470
Indirect Cost
$64,784
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Rydyznski, Carolyn E; Cranert, Stacey A; Zhou, Julian Q et al. (2018) Affinity Maturation Is Impaired by Natural Killer Cell Suppression of Germinal Centers. Cell Rep 24:3367-3373.e4
Harley, John B; Chen, Xiaoting; Pujato, Mario et al. (2018) Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet 50:699-707
Ogdie, Alexis; Sparks, Jeffrey A; Angeles-Han, Sheila T et al. (2018) Barriers and Facilitators of Mentoring for Trainees and Early Career Investigators in Rheumatology Research: Current State, Identification of Needs, and Road Map to an Inter-Institutional Adult Rheumatology Mentoring Program. Arthritis Care Res (Hoboken) 70:445-453
Martin, Lisa J; He, Hua; Collins, Margaret H et al. (2018) Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci. J Allergy Clin Immunol 141:1690-1698
Patterson, Andrew R; Endale, Mehari; Lampe, Kristin et al. (2018) Gimap5-dependent inactivation of GSK3? is required for CD4+ T cell homeostasis and prevention of immune pathology. Nat Commun 9:430
Hinks, Anne; Marion, Miranda C; Cobb, Joanna et al. (2018) Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis. Arthritis Rheumatol 70:957-962
Patel, Zubin; Lu, Xiaoming; Miller, Daniel et al. (2018) A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Hum Mol Genet :
Sherrill, Joseph D; Kc, Kiran; Wang, Xinjian et al. (2018) Whole-exome sequencing uncovers oxidoreductases DHTKD1 and OGDHL as linkers between mitochondrial dysfunction and eosinophilic esophagitis. JCI Insight 3:
Gohar, Faekah; Anink, Janneke; Moncrieffe, Halima et al. (2018) S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis. J Rheumatol 45:547-554
Nigrovic, Peter A; Raychaudhuri, Soumya; Thompson, Susan D (2018) Review: Genetics and the Classification of Arthritis in Adults and Children. Arthritis Rheumatol 70:7-17

Showing the most recent 10 out of 68 publications